El of breast and pancreatic cell lines. In this report, we

El of breast and pancreatic cell lines. In this report, we show that continued exposure to elisidepsin is correlated with a downregulation of epithelial markers in four different cancer cell types (pancreatic, breast, lung and colon). This behavior is further accompanied by several morphological and signaling changes, resulting in the upregulation of mesenchymal markers. Furthermore, we investigated the effect of the drug on the expression of HER proteins and systematically compared the elisidepsin sensitivity of cell lines overexpressing and knockingdown HER3 receptor. Finally, we identified HER3 expression as the most important sensitivity marker of elisidepsin studied.Results Cancer Cell Line Sensitivity to ElisidepsinWe performed cell viability assays in a panel of 12 cell lines (6 breast cancer cell lines and 6 pancreatic carcinoma cell lines) to determine if there was a correlation between epithelial or mesenchymal expression markers and cell sensitivity to elisidepsin. Cells were treated with increasing concentrations of the compound for 72 h. The half maximal (50 ) inhibitory concentration (IC50) values for elisidepsin, as measured by a crystal violet assay using a spectrophotometer, ranged from 0.075 to 14 mM within the cell line panel (Fig. 1A). According to the results of a previous paper from our lab and others [27,28], only those cells with an IC50 value under or equal to 1 mM are considered sensitive to the elisidepsin. MDA-MB-231, PANC-1 and MiaPaCa-2 cell lines were the only cell lines that had an IC50 value higher than 1 mM (6.5, 7.5 and 14 mM, respectively). The other cell lines were classed as being sensitive to the drug (with IC50 values ranging from 0.075 to 0.6 mM). The effect of elisidepsin is not considered to be time-dependent as no significant difference in the ratio of IC50 values was seen by Sewell et al. [7] following 1 h exposure and continuous exposure. However, when we treated the cells with continuous exposure to a subtoxic dose (i.e. lower than the IC50) the cells grew more slowly than the parental ones (Fig. 1B). Recent studies have shown that the potent cytotoxic activity of elisidepsin is buy 520-26-3 exerted very rapidly through insertion of the drug molecule into the plasma membrane, which causes a drastic loss in membrane integrity [8]. However, we found that, despite elisidepsin-induced loss of membrane integrity, those cells that remained alive after IQ-1 site treatment could recover and proliferate again (Fig. S1). This was shown by treating MCF-7 cancer cell lines with 1 mM elisidepsin for 4 h, removing the drug and measuring proliferation at different time points. More than 50 of cells died after 4 h drug treatment but when the media was replaced the cells recovered and their viability increased.lines. The protein expression of E-cadherin, b-catenin, vimentin, Slug, Snail and Twist-1 were assessed by immunocytochemical and western blot analysis, while the protein expression of Ecadherin, b-catenin, and vimentin were evaluated by immunohistochemical analysis. We aimed to determine whether the various elisidepsin-sensitive cancer cell lines shared similar basal levels of EMT genes. In the breast cancer cell lines we found E-cadherin expression in the sensitive cell lines. All cell lines had detectable expression of bcatenin, whereas Slug expression was variable and not related to their sensitivity to elisidepsin. Furthermore, Snail expression was only found in MDA-MB-435, and all the cell lines that exhibited levels.El of breast and pancreatic cell lines. In this report, we show that continued exposure to elisidepsin is correlated with a downregulation of epithelial markers in four different cancer cell types (pancreatic, breast, lung and colon). This behavior is further accompanied by several morphological and signaling changes, resulting in the upregulation of mesenchymal markers. Furthermore, we investigated the effect of the drug on the expression of HER proteins and systematically compared the elisidepsin sensitivity of cell lines overexpressing and knockingdown HER3 receptor. Finally, we identified HER3 expression as the most important sensitivity marker of elisidepsin studied.Results Cancer Cell Line Sensitivity to ElisidepsinWe performed cell viability assays in a panel of 12 cell lines (6 breast cancer cell lines and 6 pancreatic carcinoma cell lines) to determine if there was a correlation between epithelial or mesenchymal expression markers and cell sensitivity to elisidepsin. Cells were treated with increasing concentrations of the compound for 72 h. The half maximal (50 ) inhibitory concentration (IC50) values for elisidepsin, as measured by a crystal violet assay using a spectrophotometer, ranged from 0.075 to 14 mM within the cell line panel (Fig. 1A). According to the results of a previous paper from our lab and others [27,28], only those cells with an IC50 value under or equal to 1 mM are considered sensitive to the elisidepsin. MDA-MB-231, PANC-1 and MiaPaCa-2 cell lines were the only cell lines that had an IC50 value higher than 1 mM (6.5, 7.5 and 14 mM, respectively). The other cell lines were classed as being sensitive to the drug (with IC50 values ranging from 0.075 to 0.6 mM). The effect of elisidepsin is not considered to be time-dependent as no significant difference in the ratio of IC50 values was seen by Sewell et al. [7] following 1 h exposure and continuous exposure. However, when we treated the cells with continuous exposure to a subtoxic dose (i.e. lower than the IC50) the cells grew more slowly than the parental ones (Fig. 1B). Recent studies have shown that the potent cytotoxic activity of elisidepsin is exerted very rapidly through insertion of the drug molecule into the plasma membrane, which causes a drastic loss in membrane integrity [8]. However, we found that, despite elisidepsin-induced loss of membrane integrity, those cells that remained alive after treatment could recover and proliferate again (Fig. S1). This was shown by treating MCF-7 cancer cell lines with 1 mM elisidepsin for 4 h, removing the drug and measuring proliferation at different time points. More than 50 of cells died after 4 h drug treatment but when the media was replaced the cells recovered and their viability increased.lines. The protein expression of E-cadherin, b-catenin, vimentin, Slug, Snail and Twist-1 were assessed by immunocytochemical and western blot analysis, while the protein expression of Ecadherin, b-catenin, and vimentin were evaluated by immunohistochemical analysis. We aimed to determine whether the various elisidepsin-sensitive cancer cell lines shared similar basal levels of EMT genes. In the breast cancer cell lines we found E-cadherin expression in the sensitive cell lines. All cell lines had detectable expression of bcatenin, whereas Slug expression was variable and not related to their sensitivity to elisidepsin. Furthermore, Snail expression was only found in MDA-MB-435, and all the cell lines that exhibited levels.